Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool April 27, 2011 Brian Orelli	Illuminating the Growth Competition in the DNA sequencing market may be heating up, but 47% growth for Illumina isn't too shabby.
IEEE Spectrum March 2013 Eliza Strickland	The Gene Machine and Me Ion Torrent's chip-based genome sequencer is cheap, fast, and poised to revolutionize medicine
Chemistry World July 21, 2011 James Mitchell Crow	Sequencing Chip Decodes DNA Proton by Proton Technology that can directly detect the chemical reaction as a single nucleotide adds to the end of a growing strand of DNA is about to slash the cost of genome sequencing, its inventors say.
Chemistry World May 29, 2014 Hepeng Jia	Chinese-made DNA sequencer aims to challenge foreign dominance With an independently developed next-generation DNA sequencer, Chinese scientists are aiming to challenge the dominance of international players in the world's fastest growing genome sequencing market.
Chemistry World April 19, 2013 Sarah Houlton	Thermo Fisher to buy Life Technologies in $15.8bn deal Life Technologies specializes in research products, with a particular focus on genetic sequencing and DNA analysis.
Bio-IT World September 2005 Kevin Davies	Fantastic 454: DNA Sequencing Pyrotechnics In an exciting advance for DNA sequencing technology, a research team at 454 Life Sciences Corp. has essentially sequenced and assembled a bacterial genome sequence based on a mere 4-hour run on the company's proprietary instrument.
The Motley Fool August 12, 2009 Brian Orelli	The Next Big Thing Is Not Right in Front of You Perhaps the fastest evolving technology right now is found in DNA sequencing.
BusinessWeek October 23, 2008 John Carey	Reading the Entire Genetic Code Pioneers such as 23andMe and Navigenics use snips of genes to make medical predictions. Now new tools from more start-ups are on the horizon.
Bio-IT World November 14, 2003 Julia Boguslavsky	Genome Center in a Box Scientists at 454 Life Sciences developed an integrated end-to-end instrument that performs hundreds of thousands of reactions in parallel -- from sample preparation, amplification, and sequencing to data storage and bioinformatics.
The Motley Fool January 3, 2012 Alex Planes	Another Entry in the Genome Patent Rumble There's a whole lot of lawsuits going on.
Bio-IT World October 2005 Dennis A. Gilbert	The DNA Sequencing Race: From Sprint to Marathon To create faster, cheaper, and better solutions for DNA analysis, we must remain committed to improving both current and new sequencing technologies. Research that just a short while ago might have been considered too complex, too expensive, or just inconceivable is now well within our grasp.
BusinessWeek April 28, 2011 Ashlee Vance	Pacific Biosciences' $600 Million Decoder Ring Pacific Biosciences' technology may finally fulfill the dream of gene sequencing.
The Motley Fool September 28, 2006 Jack Uldrich	Is CuraGen Hiding a Genomic Gem? A majority ownership stake in 454 Life Sciences could pay hefty dividends.
The Motley Fool January 14, 2010 Brian Orelli	$1,000 Genomes, Here We Come Illumina jumps on news of its $10,000 genome.
The Motley Fool August 19, 2011 Alexander Crawford	DNA Sequencing: The Next High-Growth Market in Biotech? We compiled a list of companies with a hand in the DNA sequencing market. Should you add these companies to your watch list?
BusinessWeek November 6, 2006 Gene G. Marcial	Solexa's Progress Is In The Genes New technology makes Solexa a leading contender in the next-generation sequencing race.
Chemistry World February 21, 2012 Phillip Broadwith	Nanopore sequencing bags its first genome Oxford Nanopore has presented the first complete genome to be sequenced using a nanopore.
The Motley Fool March 30, 2007 Ralph Casale	Another Genetic Sequencer Gobbled Up Roche buys out second-generation sequencer 454 Life Sciences. Investors, take note.
The Motley Fool May 13, 2011 Karl Thiel	Pacific Biosciences Has a PR Problem PacBio is hard to break down to a sound bite, but that could spell opportunity for long-term investors.
IEEE Spectrum March 2013 Susan Hassler	Genome to Go It's already possible to have your own genome sequenced. But personalized medicine based on sequencing still has a way to go
Popular Mechanics April 25, 2008 Erik Sofge	Inside the Forgotten X Prize--the One That Can Save Your Life An extensive look at the Archon X Prize in Genomics, the $10 million race for a cheap, disease-hunting gene sequencer that could land on your kitchen counter sooner than you think.
The Motley Fool July 24, 2008 Brian Orelli	Illumina Polishes Its Biochips There's very little to complain about in Illumina's earnings report. In this market, you'll see few investors grumbling about double-digit growth.
The Motley Fool July 6, 2010 Luke Timmerman	Amazon Sees the Future of Biology in the Cloud Amazon Web Services is helping life sciences companies.
The Motley Fool November 17, 2006 Jack Uldrich	Neanderthal DNA Enlightens Investors Investors, the superb performance of 454's gene sequencing equipment on such a difficult and important project bodes well for its future prospects.
Chemistry World November 21, 2013 Phillip Broadwith	Rapid DNA sequencing cleared for the clinic The approval covers Illumina's MiSeqDx instrument, together with two diagnostic assay kits for cystic fibrosis that run on it, and a kit that allows clinical labs to develop their own diagnostic tests.
Bio-IT World February 2006 Kevin Davies	Solexa Readies 1G Genetic Analyzer Solexa, one of the firms vying to crack the $1,000 genome threshold, has officially launched its first commercial genome sequencing instrument.
Bio-IT World November 19, 2004 John Russell	GSAC Rolls On Genome Sequencing and Analysis Conference rolls on... Stephen Quake discusses research on single-molecule DNA sequencing by synthesis... A photocleavable fluorescent nucleotide for DNA sequencing and analysis...
Chemistry World February 22, 2009 Phillip Broadwith	Reading DNA Base by Base A technique to electrically detect individual DNA bases cut from a single strand of DNA has been developed by researchers in the UK.
IEEE Spectrum July 2010 Prachi Patel	Computing the Neanderthal Genome New software helped decode the DNA of our stone-age cousins
The Motley Fool May 28, 2010 Brian Orelli	Is It Time to Make Money Investing in Genetic Testing? Easier said than done.
Chemistry World January 27, 2012 Sarah Houlton	Illumina fends off Roche hostile bid Roche has made a $5.7 billion hostile bid for the genome sequencing company Illumina, after the San Diego, US-based company rejected its initial approach.
The Motley Fool December 31, 2010 Brian Orelli	3 Biotech 2010 IPOs Worthy of a Look These IPOs are worth a spot on your watchlist.
Bio-IT World April 2006 Karen Hopkin	AGBT Meeting Puts Genome Advances Front and Center If the presentations at February's Advances in Genome Biology and Technology (AGBT) are any indication, the race to generate fresh approaches to produce more sequence for less is far from over -- and looks to be heating up.
IEEE Spectrum June 2009 Prachi Patel	Advance in Nanopore Gene Sequencing Magnets help in the quest for the $1000 genome
Chemistry World April 3, 2008 Lewis Brindley	DNA Read in a Trice The prospect of treatments that are tailored to fit an individual's genetic makeup is a step closer thanks to technology unveiled by US scientists.
IEEE Spectrum February 2010 Mark Anderson	Genome as Commodity In a few years, millions will have purchased their own genome. The cultural ramifications of a $100 genome are as wide and deep as those of any other recent innovation, including search engines and cellphones.
Bio-IT World March 2006 Kevin Davies	Church Inquiry Gets Personal Harvard Medical School geneticist George Church with his plan for the Personal Genome Project is a likely contender for the X Prize that will be awarded to the group or individual that most helps cross the $1,00 genome threshold.
Wired August 2000 Jennifer Hillner	Area 22 The inside story of the first fully sequenced chromosome.
Bio-IT World January 13, 2003 Julia Boguslavsky	A Sequel to the Sequence The all-but-complete human genome sequence is not only an indispensable tool for biomedical research but also a major influence on the types of instrumentation researchers will invest in.
HHMI Bulletin May 2012 Sarah C. P. Williams	Opening the Floodgates Researchers are using exome sequencing -- zeroing in on the genes that encode proteins -- to explore the biology of certain diseases.
Salon.com June 27, 2000 Tabitha M. Powledge	Book of life? Hosanna! The Human Genome Project has been completed. We will now cure diseases, weed out defective genes and create a new supergeneration in the near future. Not.
Wired December 2002 Douglas McGray	Supermicrobe Man First Craig Venter cracked the human genome. Now he wants to sequence the ocean and save the world.
Chemistry World January 8, 2013 Andrew Turley	Illumina investment push Gene sequencing company Illumina has struck a $450 million deal to buy privately owned US firm Verinata Health, which specializes in non-invasive tests for early identification of fetal chromosomal abnormalities.
Bio-IT World Jul/Aug 2006 Kate McDonald	The Next Generation in Sequencing Is SOLiD Applied Biosystems has completed the acquisition of genetic analysis company Agencourt Personal Genomics for $120 million, and hopes to bring the company's novel next-generation sequencing technology to market next year.
The Motley Fool July 28, 2010 Brian Orelli	Now There's an Illuminating Idea Helping your customers sell more of your product makes a lot of sense.
Scientific American November 2008 Christine Soares	Contest Inspires Limb Regeneration Research Genome-sequencing contest renews regeneration research.
Bio-IT World December 10, 2002	Craig Venter Unvarnished (part II) The former Celera CEO covers privacy, ESTs, and his new research institutes.
BusinessWeek December 13, 2004 John Carey	Craig Venter: DNA's Mapmaker Who could ever have imagined that a surfer working as a night clerk at Sears, Roebuck & Co. would eventually become the driving force behind the race to read the genetic code of humanity?
The Motley Fool July 15, 2010 Nathan Alderman	What's the Market's Next Big Thing? Part 2 More Foolish ideas for market-shaking innovators.
Salon.com February 13, 2001 Arthur Allen	Size doesn't matter As scientists unveil the human genome findings, it turns out we have a lot fewer genes than we'd thought, and not many more than a fruit fly...